|
|
| MRD / Regn No. |
: MH/23-24/00020 |
Date |
: 15/07/2026 |
| Patient Name |
: ChandraSekar |
Age & Gender |
: 83 Yrs. / Male |
| Contact No. |
: 9901201342 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NO ALLERGIES |
Referred By |
: |
| |
|
| Problem
List |
: |
T2DM (21/Jun/2023) | HTN (21/Jun/2023) | ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (21/Jun/2023) | |
|
Subjective |
: |
ASYMPTOMATIC |
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 68 mg/dL | HB HEMOGLOBIN: 15.4 g/dL | WBC WHITE BLOOD CELLS: 8.37 K/uL | NEUTROPHILS: 49.1 | LYMPHOCYTES: 40 | MONOCYTES: 3.6 | PLATELETS: 280 X10^9/L | HBA1C GLYCOSYLATED HEMOGLOBIN: 6.6 mg/dL | TOTAL CHOLESTEROL: 142 1 | HDL HIGH DENSITY LIPOPROTEIN: 51 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 81 mg/dL | TGL TRIGLYCERIDE: 108 mg/dL | TOTAL T3: 130 1 | TOTAL T4: 7.66 1 | TSH THYROID STIMULATING HORMONE: 3.46 mIU/L | UREA: 32 mg/dL | CREATININE: 1.0 1 | EGFR EGLOMERULAR FILTRATION RATE: 76.01 mL/min/1.73m2 | CALCIUM: 10.05 1 | URIC ACID: 5.49 | SODIUM: 139.32 meq/L | CHLORIDE: 105.5 meq/L | TOTAL BILIRUBIN: 1.24 mg/dL | DIRECT BILIRUBIN: 0.29 mg/DL | INDIRECT BILURUBIN: 0.95 | AST ASPARTATE AMINOTRANSFERASE: 34.6 U/L | ALBUMIN: 4.4 g/dL | GLOBULIN: 3.87 | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
GLIMEPRIDE 1+ METFORMIN 500MG
GLYCOMET GP 1 |
ORAL |
1-0-0 |
BEFORE FOOD
|
90 |
|
|
2 |
CILNIDIPINE + TELMISARTAN
CILACAR-T |
ORAL |
1-0-0 |
AFTER FOOD
|
90 |
|
|
3 |
SITAGLIPTIN + DAPAGLIFLOZIN + METFORMIN
ISTAMET - D |
ORAL |
0-0-1 |
BEFORE FOOD
|
90 |
|
|
4 |
ASPIRIN + ATORVASTATIN
ECOSPORIN-AV 75 |
ORAL |
0-0-1 |
AFTER FOOD
|
90 |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 14/Aug/2026 |
| Tests Suggested For Next Visit |
: |
| |
|
| |
|
